EUVIMEDEUVIMED entdecken
Crossref

Fertility Boosters: An Overview of Drugs Used for Ovulation Induction

Farnaz Alizadeh Hooshyar, Sakineh Hajebrahimi, Soodabeh Davaran, Kimia Motlagh, Tannaz Novinbahador

International Journal of Drug Research in Clinics · 12.01.2025 · 3 · e10

DOI: 10.34172/ijdrc.2025.e10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, online erschienen am 25.05.2025. Verfasst von Farnaz Alizadeh Hooshyar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovulation induction involves using medications to stimulate ovulation. This process typically aims to promote the growth of ovarian follicles to address conditions such as anovulation. The drugs most frequently used for this purpose include gonadotropins, human chorionic gonadotropin (hCG), luteinizing hormone (LH), human menopausal gonadotropin (hMG), clomiphene citrate (CC), aromatase inhibitors such as letrozole, and follicle-stimulating hormone (FSH). Additionally, other drugs like gonadotrophin-releasing hormone (GnRH) analogs, insulin-sensitizing agents, and GnRH are also employed in ovulation induction for their specific benefits. These treatments are known to reduce the need for gonadotropins, increase the number of preovulatory follicles, and reduce endometrial thickness, all while maintaining a neutral impact on pregnancy rate.

Methods

In this review article, we gathered comprehensive information about the aforementioned medications and their mechanism of action from 2010 to 2024, utilizing Google Scholar, PubMed, and Web of Science databases.

Results

We concluded that FSH, hMG, hCG, and dopamine agonists are the most applicable medications and are more frequently prescribed in clinics. Recombinant drugs are also more cost-effective on the market.

Conclusion

Although the existing research provides generally comforting results, there remains a need for further studies to explore potential carcinogenic effects associated with drugs that stimulate ovulation.

Zitieren

APA

Hooshyar, F. A., Hajebrahimi, S., Davaran, S., Motlagh, K., & Novinbahador, T. (2025). Fertility Boosters: An Overview of Drugs Used for Ovulation Induction. International Journal of Drug Research in Clinics, 3, e10. https://doi.org/10.34172/ijdrc.2025.e10

Vancouver

Hooshyar FA, Hajebrahimi S, Davaran S, Motlagh K, Novinbahador T. Fertility Boosters: An Overview of Drugs Used for Ovulation Induction. International Journal of Drug Research in Clinics. 2025;3:e10. doi:10.34172/ijdrc.2025.e10

BibTeX
@article{Hooshyar2025,
  author = {Hooshyar, Farnaz Alizadeh and Hajebrahimi, Sakineh and Davaran, Soodabeh and Motlagh, Kimia and Novinbahador, Tannaz},
  title = {Fertility Boosters: An Overview of Drugs Used for Ovulation Induction},
  journal = {International Journal of Drug Research in Clinics},
  year = {2025},
  volume = {3},
  pages = {e10},
  doi = {10.34172/ijdrc.2025.e10}
}
Kostenlos starten →